<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" xml:lang="HR" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LV</journal-id>
<journal-id journal-id-type="nlm-ta">Lijec Vjesn</journal-id>
<journal-title-group>
<journal-title>Lijecnicki Vjesnik</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Lijec. Vjesn.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0024-3477</issn>
<issn pub-type="epub">1849-2177</issn>
<publisher><publisher-name>Croatian Medical Association</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">LV-142-24</article-id>
<article-id pub-id-type="doi">10.26800/LV-142-1-2-7</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Case report</subject></subj-group>
</article-categories>
<title-group>
<article-title>Uloga Parklandske formule u lije&#x010D;enju opse&#x017E;ne duboke opekline &#x2013; prikaz bolesnika</article-title>
<trans-title-group xml:lang="en">
<trans-title>Parkland formula role in treatment of severe burn &#x2013; Case report</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Duplan&#x010D;i&#x0107;</surname><given-names>Bo&#x017E;idar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nin&#x010D;evi&#x0107;</surname><given-names>&#x017D;eljko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Perkovi&#x0107;</surname><given-names>Mate</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Utrobi&#x010D;i&#x0107;</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Do&#x0161;enovi&#x0107;</surname><given-names>Svjetlana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vu&#x010D;emilovi&#x0107;</surname><given-names>Hrvoje</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kova&#x010D;</surname><given-names>Ruben</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Peri&#x0161;</surname><given-names>Filip</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<aff id="aff1"><label>1</label>Klinika za anesteziologiju, reanimatologiju i intenzivno lije&#x010D;enje, Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Splitu, Klini&#x010D;ki bolni&#x010D;ki centar Split</aff>
<aff id="aff2"><label>2</label>Zavod za plasti&#x010D;nu, rekonstruktivnu i estetsku kirurgiju i opekline, Klinika za kirurgiju, Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Splitu, Klini&#x010D;ki bolni&#x010D;ki centar Split</aff>
</contrib-group>
<author-notes><corresp id="cor1">Adresa za dopisivanje: Doc. prim. dr. sc. Bo&#x017E;idar Duplan&#x010D;i&#x0107;, Klinika za anesteziologiju, reanimatologiju i intenzivno lije&#x010D;enje, Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Splitu, KBC Split, Spin&#x010D;i&#x0107;eva 1, 21000 Split; e-po&#x0161;ta: <email xlink:href="bozidarduplancic@gmail.com">bozidarduplancic@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>02</month><year>2020</year></pub-date>
<volume>142</volume>
<issue>1-2</issue>
<fpage>24</fpage>
<lpage>28</lpage>
<permissions>
<copyright-year>2020</copyright-year>
<copyright-holder>Croatian Medical Association</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" specific-use="CC BY-NC-ND 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license>
</permissions>
<abstract>
<title>SA&#x017D;ETAK</title>
<p>Cilj je ovog rada prikaz bolesnika s iznimno opse&#x017E;nim opeklinama svih dijelova tijela. Mu&#x0161;karac srednjih godina 12-ak sati prije po&#x010D;etka bolni&#x010D;kog lije&#x010D;enja u KBC-u Split poku&#x0161;ao je suicid paljenjem plinske boce u zatvorenom prostoru, oko 150 kilometara od ustanove gdje je zapo&#x010D;eto lije&#x010D;enje. Eksplozija i po&#x017E;ar kojima je pacijent bio izlo&#x017E;en uzrokovali su opekline visokog stupnja na velikoj tjelesnoj povr&#x0161;ini. U trenutku prijma na bolni&#x010D;ko lije&#x010D;enje pacijent je bio ekstremno agresivan i nesuradljiv. Va&#x017E;no je naglasiti da pacijent u trenutku prijma na bolni&#x010D;ko lije&#x010D;enje nije imao uspostavljen venski put. U bolnicu je primljen sa znatnom odgodom (12 sati +/- 1 sat), koja je produbila dehidraciju i pogor&#x0161;ala njegovo, ve&#x0107; ionako &#x017E;ivotno ugro&#x017E;eno stanje. Dubina opeklina procijenjena je na stupnjeve II. b i III., a zahva&#x0107;ale su 70% ukupne povr&#x0161;ine tijela (engl. <italic>Body surface area</italic> &#x2013; BSA). Prvi cilj prije volumne nadoknade bila je uspostava odgovaraju&#x0107;ega venskog puta, koji pacijent u trenutku prijma u bolnicu nije imao. Zbog agitiranosti i agresivnosti intramuskularno se injicirala kombinacija midazolama, ketamina i atropina, a sredi&#x0161;nji venski pristup uspostavio se tek kad je pacijent bio anesteziran. Obilna nadoknada kristaloidima za vrijeme inicijalnoga trosatnog zbrinjavanja privremeno je stabilizirala bolesnika, a agresivna nadoknada kristaloidima i koloidima nastavljena je u jedinici intenzivnog lije&#x010D;enja. Potrebe za kristaloidima u prva 24 sata izra&#x010D;unane su s pomo&#x0107;u Parklandske formule i iznosile su 25.200 mL kristaloida. Tijekom lije&#x010D;enja pacijent je &#x0161;est puta podvrgnut kirur&#x0161;kim zahvatima uz svakodnevna previjanja u op&#x0107;oj anesteziji. Boravak se zakomplicirao zbog infekcije multirezistentnim <italic>Acinetobacter baumannii</italic>. Zaklju&#x010D;no, Parklandska formula ostaje okosnica volumne nadoknade pacijenata s opeklinama II. i III. stupnja. Odgoda lije&#x010D;enja, prisutna u ovom slu&#x010D;aju, rezultirala je enormnom dehidracijom i gubitkom intravaskularnog volumena sa svim patofiziolo&#x0161;kim poreme&#x0107;ajima pridru&#x017E;enima takvom stanju. Zbrinjavanje pacijenta bilo je dodatno ote&#x017E;ano zbog njegove agresivnosti pri prijmu, nedostatka venskog puta i nemogu&#x0107;nosti zapo&#x010D;injanja lije&#x010D;enja odmah ili vrlo brzo nakon nastalih opeklina.</p>
</abstract>
<trans-abstract xml:lang="en">
<title>SUMMARY</title>
<p>In this case report a rarely seen and a fairly demanding patient is presented. A middle-aged male with severe and extensive burns sustained after attempted suicide with ignited propane butane containing gas bottle was transported to the emergency department of University Hospital Centre Split after more than 12 hours since initial injury. Explosion and fire caused the second and third degree burns to the patient on a very large body surface area (70 percent). At the moment of admission, he was extremely aggressive, combative and uncooperative. Also, it is important to emphasize that the patient had no intravenous access. Due to the absence of intravenous access, and due to the patients&#x2019; condition, the author decided to apply midazolam, ketamine and atropine intramuscularly. After the patient was in general anaesthesia, central venous access was established via left subclavian vein, and immediate crystalloid infusion therapy was initiated. According Parkland formula, volume of crystalloid replacement should be 25200 mL during the first 24 hours. Since more than eight hours passed from the time of the injury, fluid deficit was theoretically more than 8400 mL. During the initial treatment and three hour surgery, the patient received 5500 mL of Plasma-Lyte solution. He was treated in the intensive care unit for a prolonged period of time, and complicated with multiresistant Acinetobacter baumannii infection. Finally, Parkland formula remains the basic tool in burn fluid resuscitation. Our intention was to present an interesting case of a middle-aged patient with extensive burns, whose care was complicated with aggression at admission, lack of intravenous access, and a prolonged period between the initial injury and the start of hospital treatment. These greatly complicate the treatment, patients&#x2019; recovery and overall morbidity and mortality.</p>
</trans-abstract>
<kwd-group kwd-group-type="author"><kwd>Deskriptori OPEKLINE &#x2013; komplikacije, lije&#x010D;enje</kwd><kwd>DEHIDRACIJA &#x2013; etiologija, lije&#x010D;enje</kwd><kwd>&#x0160;OK &#x2013; etiologija, patofiziologija</kwd><kwd>TERAPIJA TEKU&#x0106;INOM &#x2013; metode</kwd><kwd>REANIMACIJA &#x2013; metode</kwd><kwd>KRISTALOIDNE OTOPINE &#x2013; terapijska uporaba</kwd><kwd>KOLOIDI &#x2013; terapijska uporaba</kwd><kwd>OCJENA TE&#x017D;INE OZLJEDE, INFEKCIJE ACINETOBACTEROM &#x2013; farmakoterapija</kwd><kwd>ACINETOBACTER BAUMANNII</kwd><kwd>POKU&#x0160;AJ SAMOUBOJSTVA</kwd><kwd>ISHOD LIJE&#x010C;ENJA</kwd></kwd-group>
<kwd-group kwd-group-type="translator" xml:lang="en"><title>Descriptors </title><kwd>BURNS &#x2013; complications, therapy</kwd><kwd>DEHYDRATION &#x2013; etiology, therapy</kwd><kwd>SHOCK &#x2013; etiology, physiopathology</kwd><kwd>FLUID THERAPY &#x2013; methods</kwd><kwd>RESUSCITATION &#x2013; methods</kwd><kwd>CRYSTALLOID SOLUTIONS &#x2013; therapeutic use</kwd><kwd>COLLOIDS &#x2013; therapeutic use</kwd><kwd>INJURY SEVERITY SCORE</kwd><kwd>ACINETOBACTER BAUMANNII</kwd><kwd>ACINETOBACTER INFECTIONS &#x2013; drug therapy</kwd><kwd>SUICIDE, ATTEMPTED</kwd><kwd>TREATMENT OUTCOME</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Cilj je ovog rada prikaz bolesnika sa 70%-tnim subdermalnim opeklinama lica, glave, vrata, obiju ruku i nogu, prsnog ko&#x0161;a, trbuha i le&#x0111;a, a koji je primljen u bolnicu vi&#x0161;e od 12 h nakon samozapaljivanja plinskom bocom.</p>
<sec sec-type="other1">
<title>Uvod</title>
<p>U bolesnika s opeklinama uz kirur&#x0161;ko zbrinjavanje osnovna mjera o&#x017E;ivljavanja jest nadoknada volumena. Naj&#x010D;e&#x0161;&#x0107;a shema volumne nadoknade izra&#x010D;unava se prema Parklandskoj formuli koja propisuje nadoknadu volumena ovisno o postotku ope&#x010D;ene tjelesne povr&#x0161;ine (s pomo&#x0107;u tzv. pravila devetke za odraslu osobu prema kojem opeklina cijele ruke obuhva&#x0107;a 9% povr&#x0161;ine tijela, cijele noge 18%, cijele glave 9%, prednjeg dijela trupa 18% i stra&#x017E;njeg dijela trupa 18%) i tjelesnoj masi tako da se polovica volumena potrebnog u 24 sata ordinira tijekom prvih 8 sati, a ostatak tijekom sljede&#x0107;ih 16 sati. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>)</p>
</sec>
<sec sec-type="other2">
<title>Prikaz bolesnika</title>
<p>Na&#x0161; pacijent bio je 49-godi&#x0161;nji veteran Domovinskog rata, kroni&#x010D;ni psihijatrijski bolesnik koji nije uzimao terapiju za svoju bolest. U rujnu 2018. godine zaklju&#x010D;ao se u obiteljsku ku&#x0107;u i aktivirao plinsku bocu. Nakon eksplozije i po&#x017E;ara zadobio je opekline, u tom trenutku nepoznata opsega i intenziteta. Slijedilo je 10-ak sati policijskih pregovora, budu&#x0107;i da se nakon eksplozije pacijent popeo na krov obiteljske ku&#x0107;e. Nakon 10-ak sati pacijenta je svladala policija. Zatim je hitno transportiran u KBC Split. Na hitnom prijmu KBC-a Split, lokalitet Kri&#x017E;ine, pacijent je bio pothla&#x0111;en, izrazito nemiran do agresivan, bez postavljenoga venskog puta. Na svaki poku&#x0161;aj dodira postajao je agresivniji. S obzirom na nedostatak venskog puta, jedina terapijska opcija bila je aplikacija lijekova intramuskularno. U bedreni mi&#x0161;i&#x0107; ordinirano je 500 mg ketamina u kombinaciji s 10 mg midazolama i 1 mg atropina. Midazolam i atropin nu&#x017E;ni su zbog poznatih i u&#x010D;estalih nuspojava ketamina. Nakon nekoliko minuta uspostavljena je op&#x0107;a anestezija te se tako anesteziranom bolesniku u lijevu potklju&#x010D;nu venu postavio sredi&#x0161;nji venski kateter. U tom trenutku, 12-ak sati nakon nastanka opeklina, zapo&#x010D;elo se s nadoknadom volumena. Procjena potrebnog volumena nadoknade izra&#x010D;unala se prema Parklandskoj formuli. Plasti&#x010D;ni kirurg procijenio je da je pacijentu ope&#x010D;eno 70% povr&#x0161;ine tijela te da je dubina opeklina II. b i III. stupnja. Prema formuli, uz pacijentovu tjelesnu masu od 90 kg i ope&#x010D;enu povr&#x0161;inu od 70% povr&#x0161;ine tijela, trebala mu je volumna nadoknada od 25,2 litre kristaloidnih otopina tijekom prva 24 sata, odnosno 8400 mililitara u prvih 8 sati odmah nakon opekline. S obzirom na to da je nakon nastupa opekline pacijent jo&#x0161; 10-ak sati proveo na krovu obiteljske ku&#x0107;e, nadoknada volumenom teoretski je u&#x0161;la u drugu fazu prema Parklandskoj formuli. Pacijent je zatim dodatno anesteziran i relaksiran, orotrahealno intubiran i priklju&#x010D;en na strojnu ventilaciju. U&#x010D;injene su esharotomije trbu&#x0161;ne stijenke i prsnog ko&#x0161;a, gornjih i donjih udova te resekcija fleksornih retinakula obostrano (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
<fig id="f1" position="float" fig-type="figure"><label>Figure 1</label><caption><p>Escharotomy of upper, lower limbs and trunk</p></caption><graphic xlink:href="LV-142-24-f1"></graphic></fig>
<p>Tijekom navedenog zahvata koji je trajao 180 minuta ordinirano je ukupno 5,5 L otopine za infuziju <italic>Plasma-Lyte</italic>. U JIL-u se uz antibiotsku i antiulkusnu za&#x0161;titu te tromboprofilaksu nastavila obilna volumna nadoknada kristaloidnim otopinama, a zatim i koloidnim otopinama, navlastito albuminima. Infundirano je jo&#x0161; 4000 mL <italic>Plasma-Lytea</italic>, 750 mL svje&#x017E;e smrznute plazme i 100 mL 20%-tnog albumina. Prvi laboratorijski nalazi, dobiveni iz krvi uzorkovane odmah nakon prijma u jedinicu intenzivnog lije&#x010D;enja bili su: L 29,0 &#x00D7; 10<sup>9</sup>/L; E 6,4 &#x00D7; 10<sup>12</sup>/L; Hgb 170 g/L; Hct 0,55 L/L; trombociti 223 &#x00D7; 10<sup>9</sup>/L; ureja 10 mmol/L; kreatinin 196 &#x03BC;mol/L; Na 138 mmol/L; K 3,4 mol/L, a zatim, 5 sati poslije: L 25,0 &#x00D7; 10<sup>9</sup>/L; E 5,04 &#x00D7; 10<sup>12</sup>/L; Hgb 152 g/L; Htc 0,45 L/L; DKS: segmentirani 85%, nesegmentirani 4%; limfociti 2%; monociti 6%; mijelociti 2%; metamijelociti 1%. Plinska analiza u arterijskoj krvi (acidobazni status), obavljena 5 h nakon prijma u JIL, pokazala je ove vrijednosti: pH 7,22; pCO<sub>2</sub> 4,80 kPa; pO<sub>2</sub> 27,2 kPa; HCO<sub>3</sub> 13,3 mmol/L; BE -13,2 mmol/L; SaO<sub>2</sub> 99,2%. Unato&#x010D; obilnoj volumnoj nadoknadi bolesnik je imao nizak tlak, &#x0161;to je nalagalo tla&#x010D;nu potporu infuzijom noradrenalina. Pratilo se izlu&#x010D;ivanje mokra&#x0107;e, tj. satna diureza kao najbolji pokazatelj adekvatnosti nadoknade teku&#x0107;inom, a koja je iznosila 2540 mL urina u prva 24 sata, odnosno 0,4 mL/kg/h. Prvi izmjereni sredi&#x0161;nji venski tlak iznosio je 0 mmHg (10:30 sati), zatim 6 mmHg u 18:00 sati i 9 mmHg u 21:00 sat. Zbog iznimnog katabolizma, udru&#x017E;enog s opeklinama tog stupnja i opsega, neposredno nakon uspostave peristaltike odmah je zapo&#x010D;ela primjena enteralne prehrane/farmakonutricije. Tre&#x0107;eg dana izvedena je suprafascijalna nekrektomija ope&#x010D;enih dijelova tijela. Nastali defekti rekonstruirani su homolognim kadaveri&#x010D;nim slobodnim ko&#x017E;nim presadcima (transplantatima) (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
<fig id="f2" position="float" fig-type="figure"><label>Figure 2</label><caption><p>Necrectomy of lower leg with cadaveric skin transplants</p></caption><graphic xlink:href="LV-142-24-f2"></graphic></fig>
<p>Bolesnik je operiran ukupno &#x0161;est puta za vrijeme skrbi na na&#x0161;em odjelu JIL-a. Svakodnevno je previjan u op&#x0107;oj anesteziji. Osmog je dana iz krvi, obriska rane i aspirata bronha izoliran multirezistentni <italic>Acinetobacter baumannii</italic> pa se intravenski (iv.) ordiniraju kolistin i ampicilin uz sulbaktam, a kolistin i inhalacijski. Osamnaestog dana bolni&#x010D;kog lije&#x010D;enja izvedena je traheotomija. Ubrzo je u bolesnika do&#x0161;lo do septi&#x010D;kog &#x0161;oka otpornog na terapiju vazopresinom i noradrenalinom. Unato&#x010D; svim poduzetim mjerama kirur&#x0161;kog i intenzivnog lije&#x010D;enja bolesnik je, na&#x017E;alost, podlegao smrtnom ishodu nakon 32 dana bolni&#x010D;kog lije&#x010D;enja.</p>
</sec>
<sec sec-type="other3">
<title>Rasprava</title>
<p>Parklandska formula (4 mL &#x00D7; tjelesna masa (kg) &#x00D7; postotak (%) tjelesne povr&#x0161;ine zahva&#x0107;ene opeklinom) nosi ime po Memorijalnoj bolnici Parkland u Dallasu u saveznoj dr&#x017E;avi Teksas. Poznata je i pod imenom Baxterova formula prema Charlesu R. Baxteru, lije&#x010D;niku koji je radio u navedenoj bolnici i osmislio formulu. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) Cilj nadoknade teku&#x0107;inom u prva 24 sata jest hemodinamska stabilnost, a da bi se ona postigla, ope&#x010D;eni bolesnik mora primiti 4 mL kristaloida po kilogramu tjelesne mase i postotku tjelesne povr&#x0161;ine zahva&#x0107;ene opeklinom drugog ili vi&#x0161;eg stupnja. (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) Cijena hemodinamske stabilnosti jest neminovan razvoj edema u razdoblju nakon inicijalne nadoknade teku&#x0107;ine. Vi&#x0161;e od polovice svih pacijenata sa smrtnim ishodom koji je uzrokovala opeklinska ozljeda umire u prva 72 sata upravo zbog razvoja opeklinskog &#x0161;oka. (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>) Patofiziolo&#x0161;ki, opeklinski &#x0161;ok uzrokovan je gubitkom intravaskularnog volumena zbog pove&#x0107;ane propusnosti endotela i sekvestracijom teku&#x0107;ine i plazmatskih proteina u intersticij, disfunkcijom miokarda zbog o&#x0161;te&#x0107;enja mitohondrija i disfunkcijom stanica zbog hipoperfuzije (stani&#x010D;ni &#x0161;ok). Disfunkcija miokarda udru&#x017E;ena s gubitkom intravaskularnog volumena i pove&#x0107;anom sustavnom vaskularnom rezistencijom u prva 72 sata od ozljede dovodi do smanjenoga sr&#x010D;anog minutnog volumena. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Pove&#x0107;ana propusnost endotela i sekvestracija teku&#x0107;ine posljedica su sustavnog upalnog odgovora koji uzrokuju histamin, tromboksan, serotonin, kinini, citokini i reaktivni kisikovi radikali. (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) Pacijenti kod kojih &#x0107;e se razviti signifikantan sustavni upalni odgovor i najve&#x0107;i patofiziolo&#x0161;ki poreme&#x0107;aji jesu oni &#x010D;ija se opeklina (ili vi&#x0161;e njih) klasificira kao te&#x0161;ka opeklinska ozljeda, odnosno zahva&#x0107;a vi&#x0161;e od 20% povr&#x0161;ine tijela. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) U trenutku nastanka opekline gradijent prijenosa topline stvara 3 zone ozljede od kojih svaka ima svoje specifi&#x010D;nosti i zna&#x010D;enje. To su: zona koagulacije koja je potpuno uni&#x0161;tena u trenutku nastanka opekline, zatim zona staze u kojoj je zapo&#x010D;ela upala, a opskrba tkiva jo&#x0161; je odr&#x017E;ana iako je minimalna te, naposljetku, zona hiperemije u kojoj mikrocirkulacija nije oslabljena. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) Zona staze naj&#x010D;e&#x0161;&#x0107;e napreduje tijekom idu&#x0107;a 2 dana i odumire. Tako se pro&#x0161;iruju dubina i povr&#x0161;ina opekline. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) Podru&#x010D;je opekline infiltriraju aktivirani neutrofili i makrofagi koji stvaraju kisikove radikale i du&#x0161;ikov oksid (NO), a oni pridonose daljnjem o&#x0161;te&#x0107;enju ope&#x010D;enog podru&#x010D;ja. (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>) Neutrofili ne prodiru samo u podru&#x010D;je opekline, ve&#x0107; i u druge organe i tkiva u kojima stvaraju reaktivne kisikove radikale i tako dovode do disfunkcije tih organa. Smatra se da je ovaj mehanizam jedan od razloga disfunkcije pojedinih organa pri opeklinskom &#x0161;oku. (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>) Neutrofili nisu jedini razlog disfunkcije pojedinih organa jer je uo&#x010D;eno da je &#x010D;imbenik inhibicije migracije makrofaga (engl. <italic>Macrophage migration inhibitory factor</italic> &#x2013; MIF), upalni citokin, hormon i enzim, klju&#x010D;an u razvoju kasne i prolongirane sr&#x010D;ane disfunkcije. Kao &#x0161;to je ve&#x0107; navedeno, upalni odgovor na opeklinsku ozljedu uzrokuje otpu&#x0161;tanje velikog broja proupalnih medijatora koji dovode do sustavnog upalnog odgovora, vi&#x0161;eorganskog zatajenja, stanja imunosupresije i, naposljetku, sepse. (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>) S obzirom na citokinsku oluju, pitanje je mo&#x017E;e li kontinuirana venovenska hemofiltracija smanjiti mortalitet. Chung i suradnici proveli su retrospektivnu kohortnu studiju i zaklju&#x010D;ili da kontinuirana venovenska hemofiltracija znatno smanjuje mortalitet, pobolj&#x0161;ava parcijalni tlak kisika i sni&#x017E;ava dozu vazopresora potrebnu za odr&#x017E;avanje hemodinamske stabilnosti. (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>) Ograni&#x010D;enje studije sastoji se u tome da kontrolna skupina nije bila ni na kakvom obliku bubre&#x017E;ne nadomjesne terapije, ve&#x0107; je lije&#x010D;ena konzervativno. Ta je studija prou&#x010D;avala utjecaj kontinuirane venovenske hemofiltracije velikog volumena (70 mL/kg/h) pri akutnom zatajenju bubrega zbog septi&#x010D;kog &#x0161;oka uzrokovanog opeklinom velike tjelesne povr&#x0161;ine, a njezini rezultati upu&#x0107;uju na to da kontinuirana venovenska hemofiltracija velikog volumena mo&#x017E;e znatno smanjiti potrebu za vazopresorima i pobolj&#x0161;ati funkciju ostalih organa u sljede&#x0107;a dva tjedna lije&#x010D;enja. (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>) Autori nisu zabilje&#x017E;ili pad nijednog od mjerenih citokina (IL-6, IL-8, IL-10, IL-12, IFN-&#x03B3; i TNF-&#x03B1;) u periodu smanjene potrebe za vazopresorima. (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>) Jo&#x0161; nedostaju istra&#x017E;ivanja na ljudima koja bi odgovorila na pitanje mogu li membrane koje adsorbiraju citokine poput <italic>CytoSorba</italic>&#x00AE; pomo&#x0107;i u ranoj fazi opeklinske ozljede.</p>
<p>Klju&#x010D;no i nezaobilazno pitanje pri zbrinjavanju pacijenata u opeklinskom &#x0161;oku jesu tip (kristaloid, koloid) i koli&#x010D;ina teku&#x0107;ine koji &#x0107;e biti ordinirani. Va&#x017E;an &#x010D;imbenik o kojem &#x0107;e ovisiti tip teku&#x0107;ine jest i vrijeme. Pove&#x0107;ana propusnost endotela krvnih &#x017E;ila u prva 24 sata od opekline, prema nekim autorima, relativna je kontraindikacija za upotrebu albumina s obzirom na njegov potencijal da u uvjetima pove&#x0107;ane propusnosti endotela izlazi u intersticij. Goodwin i suradnici pokazali su u svojoj studiji da nadoknada kristaloidima i albuminima dovodi do pove&#x0107;ane ekstravaskularne plu&#x0107;ne teku&#x0107;ine, &#x0161;to bi govorilo u prilog nastanku edema plu&#x0107;a. (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>)</p>
<p>Hipoperfuzija i ishemija dovode do disfunkcije endotela i o&#x0161;te&#x0107;enja glikokaliksa u traumi. (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>) &#x010C;imbenici koji pridonose o&#x0161;te&#x0107;enju glikokaliksa i endotelnoj disfunkciji u traumi postoje i u slu&#x010D;aju opekline velike povr&#x0161;ine tijela. Gurney i suradnici preispituju potrebu ponovnog iskori&#x0161;tavanja plazme u nadoknadi teku&#x0107;ine kod opekline. (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>) Plazma je pokazala sposobnost za&#x0161;tite glikokaliksa i svoju nadmo&#x0107; u odnosu prema primjeni albumina kao agensa za&#x0161;tite glikokaliksa. (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>)</p>
</sec>
<sec sec-type="other4">
<title>Zaklju&#x010D;ak</title>
<p>Odgoda lije&#x010D;enja, a time i nadoknade teku&#x0107;ine kod ovog, te&#x0161;ko ope&#x010D;enog pacijenta znatno je povisila rizik od morbiditeta i mortaliteta. Prikazani bolesnik naposljetku je podlegao ozljedama nakon 32 dana intenzivnog lije&#x010D;enja. Duboke opekline velike tjelesne povr&#x0161;ine dovele su do znatnoga gubitka teku&#x0107;ine prije po&#x010D;etka bolni&#x010D;kog lije&#x010D;enja i uzrokovale golemi gubitak intravaskularnog volumena. Parklandska formula poslu&#x017E;ila je kao koristan alat i polazi&#x0161;na to&#x010D;ka pri nadoknadi volumena u ovog ope&#x010D;enog bolesnika, ali valja pratiti i druge pokazatelje uspje&#x0161;nosti resuscitacije poput satne diureze, trenda sredi&#x0161;njega venskog tlaka i/ili varijacije pulsa. Kombinacija odgode lije&#x010D;enja, opeklina velike tjelesne povr&#x0161;ine, agitiranosti pri prijmu bez venskog puta i nemogu&#x0107;nost procjene stvarnoga gubitka volumena stavljaju pred klini&#x010D;ara te&#x017E;ak zadatak s neizvjesnim ishodom lije&#x010D;enja.</p>
</sec>
</body>
<back>
<ref-list>
<title>LITERATURA</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="other">Digy S, McIntyre JK. Burn management. U: Irwin RS, Craig ML, Mayo PH, Rippe JM (ur.). Intensive Care Medicine. 8. izd. Wolter Kluwer; 2018, str. 1531.</mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>KB</given-names></name><name><surname>Khalil</surname><given-names>E</given-names></name><name><surname>Brennan</surname><given-names>A</given-names></name><etal/></person-group> <article-title>New management strategy for fluid resuscitation: quantifying volume in the first 48 hours after burn injury.</article-title> <source>J Burn Care Res</source>. <year>2013</year>;<volume>34</volume>(<issue>1</issue>):<fpage>196</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1097/BCR.0b013e3182700965</pub-id><pub-id pub-id-type="pmid">23292589</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="book">Fidler P. Burn management. U: Irwin RS, Rippe JM (ur.). Irwin and Rippe&#x2019;s Intensive Care Medicine. 7. izd. Philadelphia: Wolters Kluwer/Lippincot Williams and Wilkins; 2012, str. 1727&#x2013;32.</mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>JW</given-names></name><name><surname>Otto</surname><given-names>AM</given-names></name><name><surname>Gibran</surname><given-names>NS</given-names></name><etal/></person-group> <article-title>Trajectories to death in patients with burn injury.</article-title> <source>J Trauma Acute Care Surg</source>. <year>2013</year>;<volume>74</volume>(<issue>1</issue>):<fpage>282</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/TA.0b013e3182788a1c</pub-id><pub-id pub-id-type="pmid">23271104</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latenser</surname><given-names>BA</given-names></name></person-group>. <article-title>Critical care of the burn patient: the first 48 hours.</article-title> <source>Crit Care Med</source>. <year>2009</year>;<volume>37</volume>(<issue>10</issue>):<fpage>2819</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0b013e3181b3a08f</pub-id><pub-id pub-id-type="pmid">19707133</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keck</surname><given-names>M</given-names></name><name><surname>Herndon</surname><given-names>DH</given-names></name><name><surname>Kamolz</surname><given-names>LP</given-names></name><name><surname>Frey</surname><given-names>M</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name></person-group>. <article-title>Pathophysiology of burns.</article-title> <source>Wien Med Wochenschr</source>. <year>2009</year>;<volume>159</volume>(<issue>13&#x2013;14</issue>):<fpage>327</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/s10354-009-0651-2</pub-id><pub-id pub-id-type="pmid">19652939</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RM</given-names></name><name><surname>Richard</surname><given-names>R</given-names></name></person-group>. <article-title>Partial-thickness burns: identification and management.</article-title> <source>Adv Skin Wound Care</source>. <year>2003</year>;<volume>16</volume>(<issue>4</issue>):<fpage>178</fpage>&#x2013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1097/00129334-200307000-00010</pub-id><pub-id pub-id-type="pmid">12897674</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>A</given-names></name><name><surname>Dunn</surname><given-names>KW</given-names></name></person-group>. <article-title>Predicting length of stay in thermal burns: a systematic review of prognostic factors.</article-title> <source>Burns</source>. <year>2013</year>;<volume>39</volume>(<issue>7</issue>):<fpage>1331</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2013.04.026</pub-id><pub-id pub-id-type="pmid">23768707</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parihar</surname><given-names>A</given-names></name><name><surname>Parihar</surname><given-names>MS</given-names></name><name><surname>Milner</surname><given-names>S</given-names></name><name><surname>Bhat</surname><given-names>S</given-names></name></person-group>. <article-title>Oxidative stress and anti-oxidative mobilization in burn injury.</article-title> <source>Burns</source>. <year>2008</year>;<volume>34</volume>(<issue>1</issue>):<fpage>6</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2007.04.009</pub-id><pub-id pub-id-type="pmid">17905515</pub-id></mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwacha</surname><given-names>MG</given-names></name></person-group>. <article-title>Macrophages and post-burn immune dysfunction.</article-title> <source>Burns</source>. <year>2003</year>;<volume>29</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/S0305-4179(02)00187-0</pub-id><pub-id pub-id-type="pmid">12543039</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>KK</given-names></name><name><surname>Lundy</surname><given-names>JB</given-names></name><name><surname>Matson</surname><given-names>JR</given-names></name><etal/></person-group> <article-title>Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study.</article-title> <source>Crit Care</source>. <year>2009</year>;<volume>13</volume>(<issue>3</issue>):<fpage>R62</fpage>. <pub-id pub-id-type="doi">10.1186/cc7801</pub-id><pub-id pub-id-type="pmid">19409089</pub-id></mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>KK</given-names></name><name><surname>Coates</surname><given-names>EC</given-names></name><name><surname>Smith</surname><given-names>DJ</given-names><suffix>Jr</suffix></name><etal/></person-group> <article-title><italic>Randomized controlled Evaluation of high-volume hemofiltration in adult burn patients with Septic shoCk and acUte kidnEy injury (RESCUE) Investigators.</italic> High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial.</article-title> <source>Crit Care</source>. <year>2017</year>;<volume>21</volume>(<issue>1</issue>):<fpage>289</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-017-1878-8</pub-id><pub-id pub-id-type="pmid">29178943</pub-id></mixed-citation></ref>
<ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>CW</given-names></name><name><surname>Dorethy</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>V</given-names></name><name><surname>Pruitt</surname><given-names>BA</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury.</article-title> <source>Ann Surg</source>. <year>1983</year>;<volume>197</volume>(<issue>5</issue>):<fpage>520</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1097/00000658-198305000-00004</pub-id><pub-id pub-id-type="pmid">6342554</pub-id></mixed-citation></ref>
<ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alphonsus</surname><given-names>CS</given-names></name><name><surname>Rodseth</surname><given-names>RN</given-names></name></person-group>. <article-title>The endothelial glycocalyx: a review of the vascular barrier.</article-title> <source>Anaesthesia</source>. <year>2014</year>;<volume>69</volume>(<issue>7</issue>):<fpage>777</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1111/anae.12661</pub-id><pub-id pub-id-type="pmid">24773303</pub-id></mixed-citation></ref>
<ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurney</surname><given-names>JM</given-names></name><name><surname>Kozar</surname><given-names>RA</given-names></name><name><surname>Cancio</surname><given-names>LC</given-names></name></person-group>. <article-title>Plasma for burn shock resuscitation: is it time to go back to the future?</article-title> <source>Transfusion</source>. <year>2019</year>;<volume>59</volume> <supplement>S2</supplement>:<fpage>1578</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1111/trf.15243</pub-id><pub-id pub-id-type="pmid">30980739</pub-id></mixed-citation></ref>
<ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x00F6;tt</surname><given-names>U</given-names></name><name><surname>Solomon</surname><given-names>C</given-names></name><name><surname>Fries</surname><given-names>D</given-names></name><name><surname>Bentzer</surname><given-names>P</given-names></name></person-group>. <article-title>The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review.</article-title> <source>Scand J Trauma Resusc Emerg Med</source>. <year>2016</year>;<volume>24</volume>:<fpage>48</fpage>. <pub-id pub-id-type="doi">10.1186/s13049-016-0239-y</pub-id><pub-id pub-id-type="pmid">27068016</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
